Long-Term Cardiac Sequelae in Patients Referred into a Diagnostic Post-COVID-19 Pathway: The Different Impacts on the

Giovanna Pelà1,2, Matteo Goldoni1, Chiara Cavalli1

  • 1Department of Medicine and Surgery, University of Parma, 43100 Parma, Italy.

Insights

Long COVID can cause lasting heart problems, affecting both right and left ventricles. The severity of lung damage and hemodynamic instability influence right ventricle changes, while inflammation impacts the left ventricle.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Pulmonology

Background:

  • Persistent symptoms after COVID-19 infection are common, but long-term cardiac outcomes remain unclear.
  • Understanding the cardiac sequelae of COVID-19 is crucial for patient management and therapeutic strategy development.

Purpose of the Study:

  • To prospectively and retrospectively define the cardiac sequelae following COVID-19 infection.
  • To investigate the morpho-functional characteristics of the right (RV) and left (LV) ventricles post-COVID-19.

Main Methods:

  • A monocentric cohort study of 160 consecutive patients post-COVID-19 discharge.
  • Data collection included acute phase clinical features, ECG, echocardiography, and follow-up parameters.
  • Multivariate analysis was employed to identify independent predictors of cardiac changes.

Main Results:

  • At 5-month follow-up, echocardiography revealed RV dilation, pulmonary hypertension, and bi-ventricular systolic-diastolic dysfunction.
  • RV changes were associated with High-Resolution computed tomography (HRCT) score and hemodynamic instability (HI).
  • LV changes were independently associated with C-reactive protein levels, indicating inflammatory impact.

Conclusions:

  • COVID-19 can differentially impact the right and left ventricles.
  • RV alterations are linked to pneumonia severity and hemodynamic instability.
  • LV dysfunction may be influenced by the systemic inflammatory response post-COVID-19.
  • Long-term follow-up is essential for optimizing therapeutic interventions.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
87
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
61
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
78
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
234
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
63
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
75